高乐氏
CLX
87.09
+0.89
+1.03%
高乐氏
US · CLX
#1495 按市值排名
上市于 1970
87.09
+0.89
+1.03%
实时 - 追踪5344个代码 - 心跳于464秒前
· 2026-10-16 19:59
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了7家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 87.15% -0.06pp
- 机构数量
- 1,226 -7
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund69.38%
Hedge Fund6.08%
Public Company5.70%
Private Company2.91%
Government Pension Fund1.40%
Sovereign Wealth Fund0.90%
Family Office/Trust0.47%
Individual/Insider0.25%
Insurance Company0.11%
Other12.80%
主要股东 截至 2026-06-30
BlackRock
8.31% · 10.04M 股
Vanguard Capital Management, LLC
7.09% · 8.58M 股
State Street Global Advisors
6.97% · 8.43M 股
Vanguard Portfolio Management, LLC
4.80% · 5.80M 股
Geode Capital Management, LLC
2.70% · 3.27M 股
UBS Asset Management
2.64% · 3.19M 股
Invesco Capital Management LLC
2.63% · 3.18M 股
Van Eck Associates Corporation
2.46% · 2.97M 股
Millennium Management LLC
2.39% · 2.89M 股
Invesco Ltd.
2.34% · 2.83M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 38次买入 · 12次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Kevin Jacobsen | Chief Financial Officer | 0.09% |
| Eric Reynolds | Chief Operating Officer | 0.06% |
| Linda Rendle | Chief Executive Officer | 0.03% |
| Kirsten Marriner | Executive VP and Chief People & Corporate Affairs Officer | 0.02% |
| Pierre Breber | Independent Director | 0.01% |
| Angela Hilt | Chief Legal Officer | 0.01% |
| Chris Hyder | Group President of Health & Hygiene | 0.01% |
| Luc Bellet | Treasurer | 0.01% |
| Stacey Grier | Executive VP and Chief Growth & Strategy Officer | 0.01% |
| Nina Barton | Executive VP and Group President of Care & Connection | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-29 | Christopher Williams | Independent Director | Other Derivative Acquisition | +615 | -- |
| 2026-09-29 | Matthew John Shattock | Independent Chairperson | Other Derivative Acquisition | +903 | -- |
| 2026-09-29 | Russell Weiner | Independent Director | Other Derivative Acquisition | +643 | -- |
| 2026-09-29 | Pierre Breber | Independent Director | Other Derivative Acquisition | +459 | -- |
| 2026-09-29 | Stephanie Plaines | Independent Director | Other Derivative Acquisition | +438 | -- |
| 2026-09-22 | Angela Hilt | Chief Legal Officer | Other Acquisition | +11,436 | $83.94 |
| 2026-09-22 | Kirsten Marriner | Executive VP and Chief People & Corporate Affairs Officer | Other Acquisition | +12,389 | $83.94 |
| 2026-09-22 | Chris Hyder | Group President of Health & Hygiene | Other Acquisition | +13,342 | $83.94 |
| 2026-09-22 | Nina Barton | Executive VP and Group President of Care & Connection | Other Acquisition | +10,721 | $83.94 |
| 2026-09-22 | Linda Rendle | Chief Executive Officer | Other Acquisition | +50,988 | $83.94 |
| 2026-09-22 | Laura Peck | VP, Chief Accounting Officer & Corporate Controller | Other Acquisition | +2,192 | $83.94 |
| 2026-09-22 | Luc Bellet | Treasurer | Other Acquisition | +11,913 | $83.94 |
| 2026-07-21 | Nina Barton | Executive VP and Group President of Care & Connection | Sale to Issuer | -1,681 | $95.69 |
| 2026-07-14 | Chris Hyder | Group President of Health & Hygiene | Sale to Issuer | -277 | $94.75 |
| 2026-06-29 | Christopher Williams | Independent Director | Other Derivative Acquisition | +585 | -- |
| 2026-06-29 | Matthew John Shattock | Independent Chairperson | Other Derivative Acquisition | +820 | -- |
| 2026-06-29 | Russell Weiner | Independent Director | Other Derivative Acquisition | +595 | -- |
| 2026-06-29 | Pierre Breber | Independent Director | Other Derivative Acquisition | +395 | -- |
| 2026-06-29 | Stephanie Plaines | Independent Director | Other Derivative Acquisition | +392 | -- |
| 2026-06-16 | Angela Hilt | Chief Legal Officer | Other Acquisition | +26,324 | $94.97 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:59:24 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
高乐氏 讨论区 0 条评论